We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Penske Automotive Group
PAG
$14.2B
| $1.58M | ﹤0.01% |
30,599
+1,050
| +4% | +$51.8K |
|
|
PGRE
1552
DELISTED
Paramount Group
PGRE
| $1.58M | ﹤0.01% |
81,650
+14,050
| +21% | +$267K |
|
1553
Globus Medical
GMED
$10.8B
| $1.57M | ﹤0.01% |
62,304
+9,825
| +19% | +$239K |
|
1554
Teekay
TK
$984M
| $1.57M | ﹤0.01% |
33,720
+1,010
| +3% | +$45.2K |
|
1555
Omnicell
OMCL
$1.65B
| $1.57M | ﹤0.01% |
44,691
+4,710
| +12% | +$155K |
|
|
VSI
1556
DELISTED
Vitamin Shoppe Inc.
VSI
| $1.57M | ﹤0.01% |
38,085
+2,315
| +6% | +$97.8K |
|
1557
PTC Therapeutics
PTCT
$5.86B
| $1.57M | ﹤0.01% |
25,748
+4,505
| +21% | +$275K |
|
1558
Dorman Products
DORM
$4.11B
| $1.57M | ﹤0.01% |
31,474
+3,530
| +13% | +$166K |
|
|
RFP
1559
DELISTED
Resolute Forest Products Inc.
RFP
| $1.56M | ﹤0.01% |
90,746
+900
| +1% | +$15.5K |
|
1560
Andersons Inc
ANDE
$2.33B
| $1.56M | ﹤0.01% |
37,811
+3,920
| +12% | +$176K |
|
1561
Axos Financial
AX
$5.82B
| $1.56M | ﹤0.01% |
67,200
+9,240
| +16% | +$203K |
|
|
NFBK
1562
DELISTED
Northfield Bancorp
NFBK
| $1.56M | ﹤0.01% |
105,153
-7,700
| -7% | -$112K |
|
1563
American Homes 4 Rent
AMH
$12.4B
| $1.56M | ﹤0.01% |
94,022
+2,075
| +2% | +$34.7K |
|
|
TCF
1564
DELISTED
TCF Financial Corporation Common Stock
TCF
| $1.55M | ﹤0.01% |
49,569
+1,300
| +3% | +$39K |
|
|
ELLI
1565
DELISTED
Ellie Mae Inc
ELLI
| $1.55M | ﹤0.01% |
28,099
+3,850
| +16% | +$187K |
|
|
RDS.A
1566
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.55M | ﹤0.01% |
27,877
+41
| +0.1% | +$2.43K |
|
|
EXAM
1567
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $1.55M | ﹤0.01% |
37,305
+4,455
| +14% | +$179K |
|
|
FLTX
1568
DELISTED
Fleetmatics Group PLC
FLTX
| $1.55M | ﹤0.01% |
34,517
+4,835
| +16% | +$191K |
|
|
PTLA
1569
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.55M | ﹤0.01% |
40,750
+7,695
| +23% | +$264K |
|
1570
Unisys
UIS
$216M
| $1.55M | ﹤0.01% |
66,626
+4,705
| +8% | +$115K |
|
|
ORIT
1571
DELISTED
Oritani Financial Corp. New
ORIT
| $1.54M | ﹤0.01% |
105,819
-1,200
| -1% | -$17.4K |
|
1572
Crocs
CROX
$6.53B
| $1.54M | ﹤0.01% |
130,146
+300
| +0.2% | +$3.36K |
|
|
MTOR
1573
DELISTED
MERITOR, Inc.
MTOR
| $1.54M | ﹤0.01% |
121,918
+10,350
| +9% | +$144K |
|
1574
Clearway Energy Class C
CWEN
$5.17B
| $1.54M | ﹤0.01% |
60,548
+710
| +1% | +$18.5K |
|
|
CTLT
1575
DELISTED
CATALENT, INC.
CTLT
| $1.54M | ﹤0.01% |
49,315
+7,805
| +19% | +$225K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.